It is becoming more possible to devise genetic tests that can indicate whether an individual would be likely to suffer very serious side effects. This would permit healthcare providers to tailor ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing Leqembi up for authorization in a major market.

Genetic technology in medicine has evolved to the point where it is now being used to improve care and outcomes for ...

In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...

Researchers at the University of Copenhagen have developed a new weight-loss drug that may surpass the effectiveness of ...

Meanwhile, Hims & Hers tackles the GLP-1 shortage with a new app; Eli Lilly releases data on tirzepatide efficacy; 23andMe faces privacy concerns; and more.

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...